A new generation of artificial intelligence (AI) tools designed to allow rapid, low-cost detection of clinically actionable genomic alterations directly…
Read More »oncology
:max_bytes(150000):strip_icc()/Our_Offices_Genmab_Copenhagen_Office_Building_3_Tuala_Hjarn-3cfaf9eb11c940918115c00204877f86.jpg?w=780&resize=780,470&ssl=1 "Genmab Buys ProfoundBio for .8B to Boost Oncology Portfolio")
KEY TAKEAWAYS Danish drugmaker Genmab said Wednesday that it is buying privately held U.S. biotech firm ProfoundBio for $1.8 billion…
Read More »